Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.
about
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewNeurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapyHIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyThe influence of HLA on HIV-associated neurocognitive impairment in Anhui, ChinaPrepulse inhibition in HIV-associated neurocognitive disorders.Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.Defining cognitive impairment in people-living-with-HIV: the POPPY study.A Smartphone App to Screen for HIV-Related Neurocognitive ImpairmentCOMT Val158Met Polymorphism, Executive Dysfunction, and Sexual Risk Behavior in the Context of HIV Infection and Methamphetamine Dependence.Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power.Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients.Testing a Computerized Cognitive Training Protocol in Adults Aging With HIV-Associated Neurocognitive Disorders: Randomized Controlled Trial Rationale and Protocol.Neurocognitive effects of HIV, hepatitis C, and substance use historyHIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, BotswanaNormative data and validation of a regression based summary score for assessing meaningful neuropsychological change.The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and applicationNeurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural ChinaThe cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.Implications of hepatitis C virus infection for behavioral symptoms and activities of daily livingIncidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in ChinaNeurocognitive function in HIV-infected patients: comparison of two methods to define impairmentAsymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study.Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative menMonocyte activation in HIV/HCV coinfection correlates with cognitive impairment.The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.Allowing brief delays in responding improves event-based prospective memory for young adults living with HIV disease.Altered functional response to risky choice in HIV infection.Neurocognitive functioning in acute or early HIV infection.Cognitive function and fatigue after diagnosis of colorectal cancerElevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning.Adjuvant therapies for HIV-associated neurocognitive disorders.APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV researchWhite matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.
P2860
Q28066725-E745DBD9-2874-4685-8552-5B85CA3BE7ABQ28534903-0A81334A-B409-4091-8FDE-92CA7F5F2AF2Q28539550-44974ACE-4C5E-41C5-AA64-2E0B5BDF6CD0Q28729004-0D8F3D19-1B5F-4DA5-9697-370192FA5551Q30451688-3C2F4B03-6ED5-43FF-9FA2-CBACBDA3FBD6Q30690955-14C0EB14-5DDC-4501-9366-CC2C23216428Q30826784-51AC72C2-034C-4B0D-90F2-165CADDF13C4Q33440991-A5A82A83-62C5-402C-BB55-1F31CC1EA3EBQ33580986-96350992-9951-498C-8586-99F5B4ABA256Q33603955-39D4506A-63C2-419B-8971-4937A12BE7EBQ33640874-7CCCB996-42C3-454A-A7FF-82B033D8FAEBQ33649221-C3604A25-9159-4E87-9E1D-CD1150D974CAQ33652957-AB82C005-2A16-4E35-9DAC-97D61990105DQ33692525-F743B148-B174-441B-B879-C39FB821A407Q33716348-ACF92EE6-FF6A-4BA3-8E4E-7FC95AF79C88Q33834140-907D3774-6F87-40E0-80AD-18688F34E372Q33842454-21F1C3ED-B0CA-4E82-89BD-8A8CD9EA50B8Q33888160-26863EE5-57BF-4396-A2A1-E274A495B350Q33927844-8423E659-B169-4C22-9250-30AE640117F8Q33938797-DB4EA544-4EC2-4A7D-94E6-2C46BC91F6E4Q33969373-9EE3CBF5-7CD3-47E6-881D-8D46C07A02BCQ33969552-FED52FC6-B609-4084-9AAB-5EF089611741Q33982015-CE864647-9C2C-424D-8DD9-92C20757D4FDQ33987146-803E19E6-9E0F-42A3-8E37-4397EB303D51Q33998110-46D651D2-FD78-42F7-9EE9-D895E4F9E889Q34026010-EEDEDBF5-77D5-4ABC-B71C-6233081717A9Q34132390-C777E4F3-11E2-4E29-94D1-A66FC48247E7Q34159453-A76572EC-ABBF-4FDF-AA2B-DB7472903D35Q34243885-A042413B-568B-4A9A-8218-A5C5847301E0Q34329530-857771AC-2D68-467B-BB4C-334665D4D5D1Q34345975-490B2705-32C7-49BD-92CA-B15BC86DFC43Q34381211-61AA5AEB-25C2-423D-ABFA-99B28139E727Q34408615-1A488A1D-9651-41D9-8D8A-53319FD86A26Q34544921-09CFDAEA-48D1-41AC-B72A-D9F412527B61Q34553654-C749C21E-6C4D-4FC1-B311-CD3CD259C3F8Q34614771-6E9B9481-CA30-40E0-8533-55DF938D389EQ34692081-BBA19CE8-80C2-45A3-83FC-034DCBE211BEQ34714286-E000D8CD-E607-4FCD-A7E0-1B5EA1AD2B38Q34721127-ECEB2764-FCD9-4194-99A1-D260E378D15DQ34732904-EBBD293B-7148-4B67-9D2E-BE6363A7D67A
P2860
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Predictive validity of global ...... l impairment in HIV infection.
@en
Predictive validity of global ...... l impairment in HIV infection.
@nl
type
label
Predictive validity of global ...... l impairment in HIV infection.
@en
Predictive validity of global ...... l impairment in HIV infection.
@nl
prefLabel
Predictive validity of global ...... l impairment in HIV infection.
@en
Predictive validity of global ...... l impairment in HIV infection.
@nl
P2093
P50
P1476
Predictive validity of global ...... l impairment in HIV infection.
@en
P2093
Catherine L Carey
Emily Conover
HNRC Group
Raul Gonzalez
Thomas D Marcotte
P304
P356
10.1080/13803390490510031
P577
2004-05-01T00:00:00Z